These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 3405554)
21. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer. Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579 [TBL] [Abstract][Full Text] [Related]
22. Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary. Geisler JP; Wiemann MC; Miller GA; Geisler HE Gynecol Oncol; 1996 Mar; 60(3):424-7. PubMed ID: 8774651 [TBL] [Abstract][Full Text] [Related]
23. [Clinical studies of 145 cases of endometrial carcinoma--analysis of prognostic factors, especially pathological types]. Fukuma K; Tohya T; Souda Y; Fuzisaki S; Maeyama M; Mimori H Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1508-14. PubMed ID: 3772201 [TBL] [Abstract][Full Text] [Related]
27. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441 [TBL] [Abstract][Full Text] [Related]
28. [Prognostic value of estrogen and progesterone receptors in epidermoid carcinoma of the cervix uteri]. Gougeon E; Peyrat JP; Rohart J; Castelain B; Demaille A Rev Fr Gynecol Obstet; 1988 Jun; 83(6):411-3. PubMed ID: 3406634 [TBL] [Abstract][Full Text] [Related]
29. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691 [TBL] [Abstract][Full Text] [Related]
30. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586 [TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of the level of steroid hormone receptors in cancer of the large intestine]. Bassalyk LS; Korotkova TV; Prorokov VV; Murav'eva NI; Smirnova KD Vopr Onkol; 1987; 33(9):43-6. PubMed ID: 3660756 [TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors of endometrial carcinoma: a study of 98 cases]. Yin LJ Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):150-2, 188. PubMed ID: 8354094 [TBL] [Abstract][Full Text] [Related]
34. Prognosis of cervical cancers with reference to steroid receptors. Fujimoto J; Fujita H; Hosoda S; Okada H; Tamaya T Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):21-31. PubMed ID: 2738438 [TBL] [Abstract][Full Text] [Related]
35. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512 [TBL] [Abstract][Full Text] [Related]
37. [Multivariate analysis of prognostic factors in endometrial carcinoma]. Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208 [TBL] [Abstract][Full Text] [Related]
38. Presence of an estrogen-regulated protein in endometrial cancer. Sledge GW; Ramzy I; Dressler LG; Dorr FA; Adams DJ; McGuire WL Obstet Gynecol; 1985 Sep; 66(3):423-7. PubMed ID: 3895080 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma. Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107 [TBL] [Abstract][Full Text] [Related]
40. Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy. Robboy SJ; Bradley R Obstet Gynecol; 1979 Sep; 54(3):269-77. PubMed ID: 471366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]